Y.K. James Lau

Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members.

Weiya Xia, Y.K. James Lau, Hua Zhong Zhang et al. · PubMed · 1999 · 294 citations

Medicine, Oncology, Oral Pathology +15

Basic science of HER-2/neu: a review.

Mien‐Chie Hung, Y.K. James Lau · PubMed · 1999 · 267 citations

Medicine, Genetics, Molecular Medicine +6

Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma.

Weiya Xia, Y.K. James Lau, Hua Zhong Zhang et al. · PubMed · 1997 · 155 citations

Medicine, Oncology, Oral Pathology +10

Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel.

Lianglin Zhang, Y.K. James Lau, Weiya Xia et al. · PubMed · 1999 · 151 citations

Medicine, Oncology, Pharmacology +17

A Preliminary Study on the Efficacy of a Community-Based Physical Activity Intervention on Physical Function-Related Risk Factors for Falls Among Breast Cancer Survivors

C. Ellen Lee, Stuart J. Warden, Beth Szuck et al. · American Journal of Physical Medicine & Rehabilitation · 2016 · 23 citations

Medicine, Rehabilitation Medicine, Falls Prevention +16